A mushroom for colorectal cancer therapy
They discovered twelve unusual chemical structures belonging to a previously unknown class of compounds: terpene-nonadride heterodimers, molecules made from one terpene and one nonadride unit.
New national guidelines for anal cancer prevention in HIV patients based on UCSF research
The guidelines were published on July 9 by a panel of experts in HIV care, utilizing findings from the Anal Cancer/HSIL Outcomes Research (ANCHOR) trial led by Joel M. Palefsky, MD, a professor of medicine in the UCSF Infectious Disease Division.